Enemy on the Run?
Greetings on a very rainy Sunday morning in the Philadelphia suburbs. We are at the new home of our son Ken and his wife, Sarah, ready to attend their daughters’ ballet recital at around noon. There is something very peaceful about being in a cozy home with lots of windows, watching it pour outside. Hopefully the rain will subside when we are ready to go to the recital, and from there, drive back to DC. This week’s blog is not about politics, insurrections or shooting wars. They are important, but today I want to write about progress that transcends conflicts.
|
|
Upcoming Healthy Aging Symposium Now Accepting Abstracts
The first Healthy Aging Symposium will take place on July 14 in Fisher Colloquium in the Hariri Building. Abstracts for the symposium are now being accepted; these may feature programs, resources or research across any field relevant to aging. Submit abstracts using this form before midnight, Thursday, June 23. Abstracts selected to be displayed as posters at the symposium will be announced by June 30. Sponsored by the GUMC Center for Healthy Aging, Aging and Alzheimer’s Research Training Program, Georgetown Aging and Health Program, and Georgetown Lombardi Institute for Cancer and Aging Research.
|
|
John Theurer Cancer Center Investigators Advance Understanding of Autologous Stem Cell Transplantation in Multiple Myeloma
Three recent publications by researchers from Hackensack University Medical Center’s John Theurer Cancer Center, a part of Georgetown Lombardi, are advancing understanding of the evolving role of autologous stem cell transplantation (ASCT) in the treatment of multiple myeloma (MM). The publications underscore the continuing importance of ASCT even as the advent of several novel therapies has dramatically transformed the MM treatment landscape. Read more about this research.
|
|
Get Rolling for BellRinger
With over 320 registered riders to date, BellRinger is gearing up for a summer of riding and recruitment. Congratulations to Dr. Michael Atkins and Team Immunotherapy on leading the charge at Georgetown Lombardi with 21 riders and virtual riders recruited. Who’s next to register? Join the cause at BellRinger.org.
|
|
Invisible Discrimination: Unexplored Stories from BIPOC and Underrepresented Women in Medical Education Leadership and Professional Development Implications
Tuesday, June 14
12:00 - 1:00 p.m.
|
|
Thursday, June 16
10:00 - 11:00 a.m.
|
|
CDI Seminar Virtual Presentation
Thursday, June 16
3:00 - 4:00 p.m.
Marc Williams, PhD, postdoctoral fellow in the Department of Computational Oncology at Memorial Sloan Kettering Cancer Center, presents “Deciphering Genome Instability and Evolution in Human Tumors.” Join the seminar via Zoom.
|
|
GI Oncology Research Review
Friday, June 17
12:30 - 2:30 p.m.
Join the Ruesch Center for a review of GI oncology research from the 2022 ASCO Annual Meeting.
|
|
Tuesday, June 21
1:00 - 2:00 p.m.
This lecture series showcases Georgetown Lombardi research. Mary Beth Martin, PhD, Georgetown professor of oncology, presents “Introduction of Cancer Biology.” Join this lecture via Zoom.
|
|
Funding and Award Opportunities |
|
NEW Damon Runyon-Rachleff Innovation Award
The Damon Runyon-Rachleff Innovation Award provides funding for extraordinary early career researchers who have an innovative, new idea but lack sufficient preliminary data to obtain traditional funding. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Eligible applicants (including non-U.S. citizens) must be conducting independent research at a U.S. institution. Basic and translational/clinical projects will be considered, and individuals with a background in multiple disciplines are especially encouraged to apply. (Applications will be accepted from all scientific disciplines — e.g., chemistry, computer sciences, mathematics, engineering, physics — provided that the proposed research meets the selection criteria.) The Stage 1 award will be for two years, $200,000 per year ($400,000 total), with the Stage 2 award for up to two additional years of funding (up to four years total for $800,000). The Stage 2 award will be granted to those awardees who demonstrate significant progress on their proposed research during years one and two. View a complete award program description and application guidelines. Submit an application through proposalCENTRAL by July 6 at 4:00 p.m. ET.
|
|
NEW Small Business Transition Grant
The Small Business Transition Grant supports university researchers who would like to transition their career path from academia to a small business setting. This funding opportunity provides $400,000 as a Phase I STTR award and up to $2 million after transitioning to a Phase II SBIR. Proposed projects must fit into at least one of the following categories:
- Therapeutics and Preventative Agents
- Imaging Technologies, Interventional Devices, and In Vivo Diagnostics
- In Vitro and Ex Vivo Diagnostics and Prognostics
- Cancer Prevention and Control, Supportive Care, and Survivorship
To help facilitate the transition from junior academic scientist to entrepreneur, the selected grantees are required to secure mentoring. Therefore, the mentoring team that supports the candidate will be a critical factor in peer review. View more information and an application portal. Application due: Monday, August 22 at 5:00 p.m. ET. Learn more about this funding opportunity at a Q&A Office Hour on Tuesday, June 14 at 2:00 p.m. ET.
|
|
Request for Applications: ACS Research Priority Area: Screening
The American Cancer Society has announced a new RFA focused on testing innovative solutions to improve cancer screening and early detection. This could entail better implementing existing screening tests, adapting current tests and technologies, or developing new tools. Funds will support at least two Interdisciplinary Team Awards, seven Research Scholar Grants, and two Clinician-Scientist Development Grants. View full details on eligibility, scientific scope, application deadlines and more. Letter of Intent due June 15, submitted via proposalCENTRAL.
|
|
Gabrielle’s Angel Foundation 2022 Medical Research Awards
Gabrielle’s Angel Foundation funds promising physician scientists who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers. Applications for this year’s grants are welcome from two junior faculty members at Georgetown Lombardi – one who is conducting mainstream or conventional research and one who is conducting complementary or integrative research. Projects will be funded for a three-year period at $75,000.00 per year. View grant guidelines and application (view application as a Word doc). Electronic grant submission must be received by Friday, August 26 at grants@gabriellesangels.org; three hard copies of the application must be postmarked by that date as well.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Monthly Lecture Series – Anton Wellstein, MD, PhD | Podium A / Zoom (dial 646-558-8656; Meeting ID: 988 4150 0923)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | Ovarian Cancer – Dr. Ebony R. Hoskins – WHC | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | GVHD – Dr. Alaa Ali | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
9:00 AM | Cancer Research Data Meeting | Speakers: Marie Durr & Emily Stall | In-person in W302 NRB and Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | No Lecture | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: None
12:15 PM | No Lecture | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
